A detailed history of Interchange Capital Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Interchange Capital Partners, LLC holds 2,167 shares of NVS stock, worth $213,124. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,167
Previous 2,169 0.09%
Holding current value
$213,124
Previous $230,000 8.26%
% of portfolio
0.09%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$106.13 - $120.89 $212 - $241
-2 Reduced 0.09%
2,167 $249,000
Q2 2024

Jul 31, 2024

BUY
$92.57 - $107.37 $200,784 - $232,885
2,169 New
2,169 $230,000
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $181,508 - $210,493
2,268 New
2,268 $208,000
Q1 2021

May 05, 2021

SELL
$83.5 - $98.47 $112,057 - $132,146
-1,342 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$78.07 - $94.43 $104,769 - $126,725
1,342 New
1,342 $126,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Interchange Capital Partners, LLC Portfolio

Follow Interchange Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Interchange Capital Partners, LLC with notifications on news.